AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters

March 25, 2026 at 01:14 AM Original source
3 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
3 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

M
Merck & CoExecutive

Merck & Co is a global pharmaceutical company engaged in the development and marketing of medications.

T
Terns PharmaceuticalsExecutive

Terns Pharmaceuticals is a US-based biotechnology company focused on developing treatments for rare blood and bone marrow cancers.

Locations

Canada Foster City, California, United States Rahway, New Jersey, United States United States USA

Tags

acquisition biotech biotechnology business news cancer cancer portfolio merck mergers pharmaceuticals terns pharma

All Coverage

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQRHNPQVNLbVlNTWdRcF9KZWx5eW5MLVdra3Q4NGZFY2xGUWN1T3h5UFFOMXd5WTFsY2FOVVFYbnNXdzlDWUFfSHRYcVh0Y0Z2MnUwUzJxd19zaXl5ejlERzQ4ektPeEN0dFRlTjBtNDRTb0lVLWZLYzZJRk9PaHNPTHVGeXNPRkdfR0pjam02NGhQUkNqclBDRW0tY2RVN183dlpzcWVtTVBxZkUxMV9lalVOaVNoQ2JxcmlWdXRSVmE0aEI0djNwdlMzM2hWZVRV?oc=5" target="_blank">Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%
Uppgifter: Läkemedelsjätten i miljardaffär
Omniekonomivia ai

Det amerikanska läkemedelsbolaget Merck är i slutförhandlingar om att köpa Terns Pharmaceuticals, enligt Financial Times. Affären förväntas offentliggöras inom kort och beräknas vara värd cirka 6 miljarder dollar.

80%
Merck ultima un acuerdo de 6.000 millones de dólares para comprar la biotecnológica estadounidense Terns Pharma
El Paísvia ai

Merck & Co está cerca de cerrar un acuerdo de aproximadamente 6.000 millones de dólares para adquirir Terns Pharmaceuticals, una empresa estadounidense especializada en tratamientos para la leucemia mieloide cr ... .

80%

Similar Stories

Related coverage based on topic and tags

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters

Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters

August 25, 2026 at 06:00 PM

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters

August 28, 2026 at 11:32 AM

GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters

GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters

August 24, 2026 at 07:11 AM

Exxon, Lyondell among suitors for Shell's US chemical assets, could fetch $8 billion, FT reports - Reuters

Exxon, Lyondell among suitors for Shell's US chemical assets, could fetch $8 billion, FT reports Reuters

August 24, 2026 at 04:12 AM

The Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? - Reuters

The Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? Reuters

August 25, 2026 at 04:32 PM

US FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters

US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters

August 28, 2026 at 10:16 PM